HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone marrow transplantation in non-malignant disorders.

Abstract
From January 1992 to December 1997, 21 consecutive patients (14 SAA, 3 SCID, 1 Fanconi anemia, 1 Diamond-Blackfan anemia, 1 mucolipidosis and 1 mucopolysaccharidosis type I.) were transplanted (16 HLA-id. family, 2 MUD and 3 haploidentical family donors) in a single center. The median follow up period is 41 months (range 7-76). The probability of 3.5 year overall disease free survival is 14/21 (67%), the transplant related mortality is 4/21 (19%). All the SCID patients are alive and disease free. 3 SAA patients had signs of fungal infection prior to transplant. They died in spite of intensive antifungal treatment resulting reduced DFS for SAA to 71%. Two patients with lysosomal storage disorders (mucolipidosis and MPS I.) rejected the haploidentical T-cell depleted graft 1 and 11 months after transplant, respectively. In 2 cases non-engraftment occured, both patients were retransplanted successfully.
AuthorsG Kriván, L Timár, V Goda, M Réti, P Reményi, T Masszi
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 22 Suppl 4 Pg. S80-3 (Dec 1998) ISSN: 0268-3369 [Print] England
PMID9916644 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Anemia, Aplastic (therapy)
  • Bone Marrow Transplantation (adverse effects)
  • Child
  • Child, Preschool
  • Disease-Free Survival
  • Fanconi Anemia (therapy)
  • Female
  • Graft Rejection
  • Graft Survival
  • Humans
  • Infant
  • Lysosomal Storage Diseases (therapy)
  • Male
  • Mucolipidoses (therapy)
  • Mucopolysaccharidosis I (therapy)
  • Severe Combined Immunodeficiency (therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: